癌症遗传性倾向的电子健康交付替代方案:随机试验协议
Kimberley T Lee1,2, Briana McLeod1, Brian Egleston3
1Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
JMIR research protocols
|August 25, 2025
概括
在eREACH研究中对转移性癌症患者进行基因检测的数字干预进行了测试,旨在改善获取和结果. 结果尚未公布, 但这种方法可能会扩大基因测试的可用性.
科学领域:
- 癌症学
- 遗传学
- 数字健康
背景情况:
- 基因线BRCA1/2检测是癌症风险,查和PARP抑制剂的标准.
- PARP 抑制剂已被批准用于转移性乳腺癌,卵巢癌,胰腺癌和前列腺癌,增加了检测指示.
- 许多有风险的患者无法获得遗传服务,
研究的目的:
- 这项eREACH研究评估了癌症遗传检测中传统遗传咨询的电子健康 (数字) 替代方案.
- 它评估了这种数字干预对转移性乳腺癌,卵巢癌,胰腺癌或前列腺癌患者的有效性.
- 目的是确定数字传递是否是识别PARP抑制剂候选者的可行选择.
主要方法:
- 一个随机的非劣势研究 (2x2设计) 将数字干预与标准遗传咨询进行比较.
- 患有转移性癌症的参与者接受了全方位咨询,混合咨询/数字化或全方位数字化干预.
- 主要测量结果是基因知识和焦虑从基线到披露后的变化.
主要成果:
- 截至2025年1月,已完成229名参与者的招生.
- 数据分析正在进行中,预计结果将于2025年公布.
- 该研究将确定数字干预是否与标准护理无差.
结论:
- 越来越需要替代性基因测试交付模式来改善获取和采用.
- 该研究评估了以患者为中心的交互式数字干预,用于转移性癌症的临床遗传测试.
- 预计这些发现将为基因检测提供指导方针和护理标准提供信息,并可能具有更广泛的适用性.
更多相关视频
10:35A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction
Published on: April 5, 2018
10.5K
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
1.2K
相关概念视频
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Cancer Prevention
6.3K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.3K
